Antidepressant Proposer
source

Antidepressant Proposer

(6)
Price
Free
Category
Medical Education
Last update
Mar 24, 2026
Publisher
Theodore Huzyk, MD Inc Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
6
Avg rating,
total
⭐5.0
Loading...

Description

1214 chars

An app that assigns scores for 32 antidepressants on 20 different commonly encountered patient factors/drug measures. Multiple attributes can be selected at once and scores summed to provide an estimated overall ranking of suitability. Explanations for scoring of each attribute is provided, with links to UpToDate and other supporting primary literature. Antidepressant drugs include: citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, agomelatine, bupropion, mirtazapine, desvenlafaxine, levomilnacipran, milnacipran, venlafaxine, nefazodone, trazodone, vilazodone, vortioxetine, amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, maprotiline, nortriptyline, protriptyline, trimipramine, isocarboxazid, phenelzine, selegiline, tranylcypromine, and duloxetine. Ranked measures include: anticholinergic, drowsiness, insomnia/agitation, orthostasis, QTc prolongation, GI toxicity, weight gain, sexual dysfunction, antidepressant-naive, pregnant, breastfeeding, chronic pain, suicide (overdose) risk, cost, drug-drug interaction risk, renal impairment, hepatic impairment, antidepressant efficacy, all-cause discontinuation, and discontinuation due to side effects.

Screenshots

https://is1-ssl.mzstatic.com/image/thumb/Purple128/v4/07/d9/4b/07d94b9f-58a8-6aa2-d4f2-9d43198b4a73/pr_source.png/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple118/v4/03/ae/01/03ae0121-bfbf-084d-4410-1c20beb9c8a0/pr_source.png/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple128/v4/5e/7b/29/5e7b2973-50b8-1dc4-a94d-05e32ba6a523/pr_source.png/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple128/v4/20/60/dd/2060dd8d-7c84-9c51-892f-53b772edfec9/pr_source.png/2048x2732.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple118/v4/bd/ef/25/bdef2508-9908-02be-6146-546e2173fd12/pr_source.png/2048x2732.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster